Comparison of integrated positron emission tomography/computed tomography and mediastinoscopy in mediastinal staging of non-small cell lung cancer: Analysis of 212 patients

Acta Chirurgica Belgica

Volumn 112, Issue 3, 2012, Pages 219-225

  Iskender, I ^a,c   Kapicibasi, H O ^b   Kadioglu, S Z ^b   Sevilgen, G ^a   Tezel, C ^a   Kosar, A ^a   Atasalihi, A ^a   Kir, A ^a  

^a Cizre Dr Selahattin Cizrelioglu State Hospital   (Turkey)

^b Sureyyapasa Chest Diseases and Thoracic Surgery Teaching and Research Hospital   (Turkey)

^c CIZRE STATE HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862225470     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2012.11680827     Document Type: Article

References (24)

1. Cerfolio R. J., Ojha B., Bryant A. S., Raghuveer V., Mountz J. M., Bartolucci A. A. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with non-small cell lung cancer. Ann Thorac Surg, 2004, 78: 1017-1023.
2. Lardinois D., Weder W., Hany T. F. et al. Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med, 2003, 348: 2500-2507.
3. Turkmen C., Sonmezoglu K., Toker A. et al. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Clin Nucl Med, 2007, 32: 607-612.
4. Takamochi K., Yoshida J., Murakami K. et al. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer, 2005, 47: 235-242.
5. Raviglione M. C., Snider D. E. Jr., Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA, 1995, 273: 220-226.
6. nd edition). Chest, 2007, 132: 202-220.
7. De Leyn P., Lardinois D., Van Schil P. E. et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg, 2007, 32: 1-8.
8. GraeterT. P, Hellwig D., Hoffmann K., UkenaD., Kirsch C. M., Schafers H. J. Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18fluorodeoxyglucose and mediastinoscopy. Ann Thorac Surg, 2003, 75: 231-235.
9. Mountain CF., Dressler CM. Regional lymph node classification for lung cancer staging. Chest, 1997, 111: 1718-1723.
10. Mountain CF. Revisions in the international system for staging lung cancer. Chest, 1997, 111: 1710-1717.
11. Melek H., Gunluoglu M. Z., Demir A., Akin H., Olcmen A., Dincer S. I. Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer. Eur J Cardio -thorac Surg, 2008, 33: 294-299.
12. Lee B. E., Redwine J., Foster C. et al. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3. J Thorac Cardiovasc Surg, 2008, 135: 615619.
13. Gonzalez-Stawinski G. V., Lemaire A., Merchant F. et al. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J Thorac Cardiovasc Surg, 2003, 126: 1900-1905.
14. Al-Sarraf N., Aziz R., Gately K. et al. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Eur J Cardiothorac Surg, 2008, 33: 104-109.
15. Toloza E. M., Harpole L., Detterbeck F., McCrory D. C. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest, 2003, 123: 157-6.
16. Verhagen A. F., Bootsma G. P., Tjan-Heijnen V. C. et al. FDG-PET in staging lung cancer: how does it change the algorithm ? Lung cancer, 2004, 44: 175-181.
17. Lee P C., Port J. L., Korst R. J., Liss Y., Meherally D. N., Altorki N. K. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg, 2007, 84: 177-181.
18. Cerfolio R. J., Bryant A. S., Eloubeidi M. A. Routine medi-astinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study. Chest, 2006, 130: 1791-1795.
19. Yasufuku K., Nakajima T., Motoori K. et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest, 2006, 130: 710-718.
20. Rusch V. W., Asamura H., Watanabe H., Giroux D. J., Rami-Porta R., Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol, 2009, 4: 568-577.
21. Lopez L., Varela A., Freixinet J. et al. Extended cervical medi-astinoscopy: prospective study of fifty cases. Ann Thorac Surg, 1994, 57: 555-557.
22. Call S., Rami-Porta R., Serra-Mltjans M. et al. Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma of the left lung. Eur J Cardiothorac Surg, 2008, 34: 1081-1084.
23. Lemaire A., Nikolic I., Petersen T. et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann Thorac Surg, 2006, 82: 1185-1189.
24. Hammoud Z. T., Anderson R. C., Meyers B. F. et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg, 1999, 118: 894-899.